Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina: Cohort study with evaluation of the ergonovine coronary spasm induction test

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 9, 2007, Pages 573-581

  Io, Kensuke ^a   Minatoguchi, Shinya ^b   Nishigaki, Kazuhiko ^b   Ojio, Shinsuke ^b   Tanaka, Tsutomu ^a   Segawa, Tomonori ^c   Matsuo, Hitoshi ^c   Watanabe, Sachiro ^c   Hattori, Arihiro ^d   Ueno, Katsumi ^d   Ono, Hiroyoshi ^e   Hiei, Kunihiko ^e   Sato, Hironobu ^f   Morita, Norihiko ^f   Noda, Toshiyuki ^g   Kato, Toshihiko ^g   Kawasaki, Masanori ^b   Takemura, Genzou ^b   Fujiwara, Hisayoshi ^b  

^a Chuno Kosei Hospital   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Gifu Municipal Hospital   (Japan)

^d GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^e Ibi General Hospital   (Japan)

^f Matsunami General Hospital   (Japan)

^g Gifu Red Cross Hospital   (Japan)

Author keywords

Antihypertensives; Benidipine; Calcium channel blockers; CAS 91599 74 5; Coronary artery spasm, total spasm; Coronary heart disease; Ergonovine, coronary spasm induction test; Vasospastic angina, prognosis

Indexed keywords

AMLODIPINE; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NIFEDIPINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; VASOSPASM;

EID: 35048896044     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296652     Document Type: Article

References (25)

1. Van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med. 2000;342:1-8.
2. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol. 1988;18:331-349.
3. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999; 33:1442-1452.
4. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000;101:1102-1108.
5. Hillis LD, Braunwald E. Coronary-artery spasm. N Engl J Med. 1978;299:695-702.
6. Maseri A, Severi S, Nes MD, L'Abbate A, Chierchia S, Marzilli M, et al. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978;42:1019-1035.
7. Ito A, Fukumoto Y, Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol. 2004;44:480-485.
8. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988;78:1-9.
9. Yamagishi M, Ito K, Tsutsui H, Miyazaki S, Goto Y, Nagaya N, et al. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists. Circ J. 2003;67:1029-1035.
10. Waters DD, Miller DD, Szlachcic J, Bouchard A, Methe M, Kreeft K, et al. Factors influencing the long-term prognosis of treated patients with variant angina. Circulation. 1983;68:258-265.
11. Mark DB, Califf RM, Morris KG, Harrell FE Jr, Pryor DB, Hlatky MA, et al. Clinical characteristics and long-term survival of patients with variant angina. Circulation. 1984; 69:880-888.
12. Healthy bureau, The Ministry of Health, Labour and Welfare. Diabetic investigation of actual conditions report in 2002 fiscal year. Tokyo: The Ministry of Health, Labour and Welfare, Tokyo; 2004.
13. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982;65:1299-1306.
14. Song JK, Park SW, Kang DH, Hong MK, Kim JJ, Lee CW, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol. 2000;35:1850-1856.
15. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, et al. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation. 1995;92:1749-1757.
16. Schroeder JS, Lamb IH, Bristow MR, Ginsburg R, Hung J, McAuley BJ. Prevention of cardiovascular events in variant angina by long-term diltiazem therapy. J Am Coll Cardiol. 1983;1:1507-1511.
17. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327-333.
18. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 1996;276:889-897.
19. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol. 1994;23:352-357.
20. Suzuki H, Kawai S, Aizawa T, Kato K, Sunayama S, Okada R, et al. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol. 1999;33:198-205.
21. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol. 1998;32:1672-1679.
22. Moriyama T, Karasawa A. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Biol Pharm Bull. 1994;17:1468-1471.
23. Karasawa A, Kubo K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol. 1988;47:35-44.
24. Yao K, Ina Y, Nagashima K, Ohmori K, Ohno T. Antioxidant effects of calcium antagonists in rat brain homogenates. Biol Pharm Bull. 2000;23:766-769.
25. Wang N, Minatoguchi S, Chen XH, Arai M, Uno Y, Lu C, et al. Benidipine reduces myocardial infarct size involving reduction of hydroxyl radicals and production of protein kinase C-dependent nitric oxide in rabbits. J Cardiovasc Pharmacol. 2004;43:747-757.